The Asia Pacific Cell Fractionation Market was worth USD 0.69 Billion in 2018 and estimated to be growing at a CAGR of 10.7%, to reach USD 1.15 Billion by 2023. The market is projected to show significant growth during the forecasting period and will continue to grow in the following years because of the ongoing development in biotechnology sector.
Cell fractionation, or in other terms, Cell Lysis, is the process which separates cellular parts yet completely retains the independent features of each of them. It involves the breaking of cell membrane by different mechanisms. Cell fractionation facilitates the study of various parts of cells individually and scientists can thus find out their biochemical function and structure.
The major driving forces of the growth of the Cell Fractionation market in Asia Pacific are increase in aged population, stabilizing economy and development in the biotechnology sector. The major constraints for the growth of this market are high requirement of capital and time, lack of government support and lack of skilled expertise.
The Asia Pacific Cell Fractionation market is broadly categorized on the basis of Product into Consumables, Reagents, Beads, Disposables and Instruments. The consumables segment leads the market. The reagents segment is further sub-segmented into Enzymes and Detergent solutions whereas the Instruments segment is sub-segmented into Sonicator and Homogenizer. On the basis of Type of Cell, the segmentation of the market is Microbial and Mammalian wherein the mammalian segment leads the market because of rising aging population. Lastly, on the basis of End User, the market is segmented into Research Laboratories, Biopharmaceutical & Biotechnology Companies.
On the basis of region the Asia Pacific market is segmented into China, India, Japan and South korea. Developing countries like India and China have been undergoing a lot of technological development and thus provide a good market for Cell fractionation. This region has the highest CAGR on a global level.
The major players dominating the Cell Fractionation market are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signalling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Reagents
5.1.3.1 Enzymes
5.1.3.2 Detergent Solutions
5.1.4 Beads
5.1.5 Disposables
5.1.6 Instruments
5.1.6.1 Sonicator
5.1.6.2 Homogenizer
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Type of cell
5.2.1 Introduction
5.2.2 Microbial
5.2.3 Mammalian
5.2.4 Y-o-Y Growth Analysis, By Type of cell
5.2.5 Market Attractiveness Analysis, By Type of cell
5.2.6 Market Share Analysis, By Type of cell
5.3 End Users
5.3.1 Introduction
5.3.2 Research Laboratories and Institutes
5.3.3 Biopharmaceutical Companies
5.3.4 iotechnology Companies
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of cell
6.1.3.4 By End Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Beckman Coulter
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Bio-Rad Laboratories
8.5 Cell Signaling Technology
8.6 Miltenyi Biotec
8.7 Thermo Fisher Scientific Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
